[go: up one dir, main page]

GB0805312D0 - Modulation of the immune response - Google Patents

Modulation of the immune response

Info

Publication number
GB0805312D0
GB0805312D0 GBGB0805312.6A GB0805312A GB0805312D0 GB 0805312 D0 GB0805312 D0 GB 0805312D0 GB 0805312 A GB0805312 A GB 0805312A GB 0805312 D0 GB0805312 D0 GB 0805312D0
Authority
GB
United Kingdom
Prior art keywords
modulation
immune response
immune
response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0805312.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB0805312.6A priority Critical patent/GB0805312D0/en
Publication of GB0805312D0 publication Critical patent/GB0805312D0/en
Priority to PCT/GB2009/000739 priority patent/WO2009115807A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/7125Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/713Double-stranded nucleic acids or oligonucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0805312.6A 2008-03-20 2008-03-20 Modulation of the immune response Ceased GB0805312D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0805312.6A GB0805312D0 (en) 2008-03-20 2008-03-20 Modulation of the immune response
PCT/GB2009/000739 WO2009115807A1 (en) 2008-03-20 2009-03-19 Inhibitors of the aryl hydrocarbon receptor for modulating the immune response

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0805312.6A GB0805312D0 (en) 2008-03-20 2008-03-20 Modulation of the immune response

Publications (1)

Publication Number Publication Date
GB0805312D0 true GB0805312D0 (en) 2008-04-30

Family

ID=39386624

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0805312.6A Ceased GB0805312D0 (en) 2008-03-20 2008-03-20 Modulation of the immune response

Country Status (2)

Country Link
GB (1) GB0805312D0 (en)
WO (1) WO2009115807A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011131246A1 (en) * 2010-04-22 2011-10-27 Institut Gustave Roussy Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
WO2012007783A1 (en) * 2010-07-13 2012-01-19 Institut Gustave Roussy Kits and methods for detecting the ability to induce an immunogenic cancer cell death in a subject
WO2012015914A2 (en) 2010-07-27 2012-02-02 Trustees Of Boston University Aryl hydrocarbon receptor (ahr) modifiers as novel cancer therapeutics
CA2840408A1 (en) * 2011-06-27 2013-01-03 Galderma Research & Development New th-17 differentiation markers for rosacea and uses thereof
JP6980534B2 (en) 2015-06-25 2021-12-15 ザ チルドレンズ メディカル センター コーポレーション Methods and Compositions for Enlargement, Enrichment, and Maintenance of Hematopoietic Stem Cells
JP7080179B2 (en) 2016-03-15 2022-06-03 ザ チルドレンズ メディカル センター コーポレーション Methods and Compositions for Hematopoietic Stem Cell Growth
CN110215448B (en) * 2018-03-02 2022-09-20 中国医学科学院基础医学研究所 Drug containing transport protein inhibitor, pharmaceutical composition and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002332878A1 (en) * 2001-09-06 2003-03-24 Synorx, Inc. Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
EP1418164A1 (en) * 2002-11-07 2004-05-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists
WO2007041495A2 (en) * 2005-09-29 2007-04-12 University Of California, San Diego Dampening humoral and innate immunity by inhibition of ppgalnact-1
CA2635445A1 (en) * 2006-02-22 2007-08-30 University Of Zurich Methods for treating autoimmune or demyelinating diseases

Also Published As

Publication number Publication date
WO2009115807A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
IL199969A0 (en) Methods of modulating immune function
IL215292A0 (en) Compounds and methods for modulating an immune response
IL209975A0 (en) Anti-cd5 antibodies
GB0801032D0 (en) Immune modulation
GB201005931D0 (en) Immune modulation
EP2276833A4 (en) MODULATION OF THE IMMUNE RESPONSE
GB0805312D0 (en) Modulation of the immune response
GB0911258D0 (en) The feedifier
GB2476767B (en) Method of modifying the immune response
GB201004327D0 (en) The artin
GB0818787D0 (en) The permenforce cruth
HK1153772A (en) Modulation of the immune response
PL384973A1 (en) The manner of obtaining of eritritol
GB0814144D0 (en) The retailer
AP2675A (en) The distrubution of eletricity
GB0800715D0 (en) The Smartsack
GB0806847D0 (en) The karkip
GB0814358D0 (en) The buggybasket
GB0817587D0 (en) The milkbox
GB0818378D0 (en) The yazee
GB0808155D0 (en) The lilolift
GB0807757D0 (en) The wellie-checker
GB0800503D0 (en) The cliffie
GB0820570D0 (en) The boatglider
GB0821263D0 (en) The mini-room

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)